Breaking News
Investing Pro 0
Black Friday SALE: Up to 54% OFF InvestingPro+ CLAIM OFFER

Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday

Stock Markets Sep 09, 2022 10:10
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
 
IXIC
-0.52%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
TGTB34
+3.65%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
PIXY
+7.75%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Gainers

  • ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.
  • Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) gained 51% to settle at $27.03 after the FDA Advisory Committee voted that available evidence of effectiveness is sufficient to support approval of AMX0035 for the treatment of ALS. Citigroup (NYSE:C) and SVB Leerink raised their price targets.
  • Rubius Therapeutics, Inc. (NASDAQ: RUBY) climbed 48.6% to close at $1.29 after declining 11% on Wednesday. Rubius Therapeutics, last month, posted a Q2 loss of $0.49 per share.
  • Benitec Biopharma Inc. (NASDAQ: BNTC) shares gained 33% to close at $0.7880. The company, last week, filed its annual report on Form 10-K for the quarter ended June 30, 2022, with the U.S. Securities and Exchange Commission.
  • Marker Therapeutics, Inc. (NASDAQ: MRKR) rose 31.5% to close at $0.3999 after the company's Phase 2 study of multi-tumor-associated antigen-specific T cell therapy for relapsed/refractory AML appeared on the FDA's Orphan Products Grants Program site.
  • Palatin Technologies, Inc. (NYSE: PTN) gained 26.2% to close at $6.31 after the company announced the initiation of patient recruitment for its Phase 2 study evaluating oral PL8177 in ulcerative colitis.
  • LifeStance Health Group, Inc. (NASDAQ: LFST) jumped 25.8% to close at $9.57. LifeStance Health named Ken Burdick as CEO and Chairman.
  • T Stamp Inc. (NASDAQ: IDAI) gained 25% to settle at $1.85.
  • Asana, Inc. (NYSE: ASAN) shares gained 24.8% to close at $23.76 after the company reported better-than-expected results for its second quarter and issued a strong sales guidance. RBC Capital and Citigroup raised their price targets on the stock.
  • Relay Therapeutics, Inc. (NASDAQ: RLAY) gained 23.8% to close at $31.37. Relay Therapeutics announced efficacy of RLY-4008, a highly selective FGFR2 inhibitor in patients with a FGFR2-fusion or rearrangement FGFR inhibitor-naïve cholangiocarcinoma: ReFocus trial.
  • Revance Therapeutics, Inc. (NASDAQ: RVNC) gained 21.6% to close at $25.30 after the company announced FDA approval of DAXXIFY for injection for temporary improvement of moderate to severe frown lines.
  • SPAR Group, Inc. (NASDAQ: SGRP) rose 21.3% to close at $1.54 after the company's board of directors initiated a process to evaluate potential strategic alternatives including a sale, merger or other strategic transaction.
  • Allarity Therapeutics, Inc. (NASDAQ: ALLR) rose 20.4% to settle at $1.30.
  • Eve Holding, Inc. (NYSE: EVEX) jumped 20% to close at $7.39. United reported a $15 million investment in Eve Air Mobility and a conditional purchase agreement for 200 four-seat electric aircraft plus 200 options.
  • Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) climbed 18.9% to settle at $708.85 after the company announced that the primary endpoints were met in two pivotal trials investigating novel aflibercept 8 mg with 12- and 16-week dosing regimens in patients with diabetic macular edema and wet age-related macular degeneration.
  • Eyenovia, Inc. (NASDAQ: EYEN) gained 18.6% to close at $2.48.
  • VistaGen Therapeutics, Inc. (NASDAQ: VTGN) jumped 18.4% to close at $0.1953 after the company announced the completion of an interim analysis of its PALISADE-2 Phase 3 clinical trial of PH94B.
  • IVERIC bio, Inc. (NASDAQ: ISEE) gained 18.3% to settle at $17.68 after Stifel maintained a Buy rating on the stock and raised its price target from $28 to $35.
  • First High-School Education Group Co., Ltd. (NYSE: FHS) gained 17% to close at $0.75.
  • Lyft , Inc. (NASDAQ: NASDAQ:LYFT) gained 16.9% to close at $17.17 amid vague rumors from a questionable source mentioning the company.
  • NantHealth, Inc. (NASDAQ: NH) jumped 16.4% to close at $0.4788.
  • Venus Concept Inc. (NASDAQ: VERO) gained 15.8% to close at $0.7473.
  • Annovis Bio, Inc. (NYSE: ANVS) climbed 15.7% to settle at $12.19 after HC Wainwright & Co initiated coverage on the stock with a Buy rating and announced a $40 price target.
  • Phreesia, Inc. (NYSE: PHR) rose 15.6% to close at $27.64 after the company reported better-than-expected Q2 sales results and raised the low-end of its FY23 sales guidance.
  • Tandem Diabetes Care, Inc. (NASDAQ: TNDM) jumped 15.3% to close at $52.61.
  • AeroVironment, Inc. (NASDAQ: AVAV) gained 14.9% to close at $101.87 after reporting upbeat quarterly sales.
  • Immunocore Holdings plc (NASDAQ: IMCR) rose 14.9% to settle at $57.44 after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced an $82 price target.
  • Terns Pharmaceuticals, Inc. (NASDAQ: TERN) gained 14.7% to close at $4.36.
  • Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) rose 14.4% to close at $23.86. Rhythm Pharmaceuticals announced new employment inducement grants. Goldman Sachs (NYSE:GS) maintained Rhythm Pharmaceuticals with a Buy and raised the price target from $28 to $31.
  • Cazoo Group Ltd (NYSE: CZOO) gained 13.5% to close at $0.6921. The company announced it will wind down operations in mainland Europe to focus on core UK market.
  • PROCEPT BioRobotics Corporation (NASDAQ: PRCT) jumped 11.3% to close at $49.93.
  • Rivian Automotive, Inc. (NASDAQ: RIVN) gained 10.9% to close at $36.88 after the company and Mercedes-Benz Vans signed a Memorandum of Understanding for a strategic partnership.
  • John Wiley & Sons, Inc. (NYSE: WLY) gained 10.8% to settle at $46.08. CJS Securities upgraded John Wiley & Sons from Market Perform to Market Outperform.
  • Allego N.V. (NYSE: ALLG) rose 9.6% to close at $4.33. Allego recently announced first half financial results and 2022 revenue expectations.
  • Heliogen, Inc. (NYSE: HLGN) rose 9.5% to close at $2.42.
  • Albireo Pharma, Inc. (NASDAQ: ALBO) surged 9.4% to close at $18.23. Guggenheim initiated coverage on Albireo Pharma with a Buy rating and announced a price target of $55.
  • Snap Inc . (NYSE: NYSE:SNAP) rose 9.3% to close at $12.53 on continued strength after a recent internal memo obtained by The Verge suggested the company is aiming to reach $6 billion in revenue and 450 million users by next year.
  • Intapp, Inc. (NASDAQ: INTA) rose 8.5% to close at $15.95 after the company reported better-than-expected Q4 results and issued guidance above estimates.
  • GameStop Corp . (NYSE: NYSE:GME) rose 7.5% to close at $25.83 after the company reported better-than-expected earnings for its second quarter and also announced a partnership with cryptocurrency exchange FTX to bring more customers to the digital asset space.
  • Zillow Group, Inc. (NASDAQ: ZG) gained 6.3% to close at $37.58 after Jefferies maintained a Buy rating on the stock and raised its price target from $48 to $50.
Losers
  • Troika Media Group, Inc. (NASDAQ: TRKA) dipped 26.8% to settle at $0.4756 on Thursday after declining around 6% on Wednesday.
  • Great Panther Mining Limited (NYSE: GPL) shares tumbled 25.9% to close at $0.2396. The company recently announced it has determined to file a notice of intention to make a proposal under the Bankruptcy and Insolvency Act, which will provide credit protection.
  • PlayAGS, Inc. (NYSE: AGS) shares fell 20.2% to close at $6.07.
  • Ensysce Biosciences, Inc. (NASDAQ: ENSC) fell 19.7% to close at $0.3313.
  • a.k.a. Brands Holding Corp. (NYSE: AKA) dipped 19.2% to close at $2.36.
  • Globalstar, Inc. (NYSE: GSAT) fell 18.9% to settle at $1.67 amid possible profit taking. The stock gained on Wednesday after the company announced it will be the satellite operator for Apple (NASDAQ:AAPL) satellite-enabled services.
  • Biophytis S.A. (NASDAQ: BPTS) declined 17.7% to close at $0.9139. Biophytis recently announced top-line results from its phase 2-3 COVA clinical study evaluating Sarconeos in the treatment of COVID-19-related respiratory failure.
  • Golden Path Acquisition Corporation (NASDAQ: GPCO) fell 16.7% to close at $7.40.
  • VirnetX Holding Corp (NYSE: VHC) dipped 16.6% to close at $1.56.
  • Addentax Group Corp. (NASDAQ: ATXG) dropped 15.7% to settle at $5.22.
  • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) fell 15.5% to close at $30.76.
  • Nogin, Inc. (NASDAQ: NOGN) declined 15.4% to close at $1.71.
  • Bilibili Inc. (NASDAQ: BILI) fell 15% to close at $20.07 following Q2 results.
  • Skillsoft Corp. (NYSE: SKIL) fell 14.9% to close at $2.29 after the company posted downbeat quarterly sales and authorized a $30 million share buyback.
  • Tandy Leather Factory Inc. (NASDAQ: TLF) fell 14.8% to close at $5.24 following uplisting of its stock.
  • Dave & Buster's Entertainment, Inc. (NASDAQ: PLAY) dropped 14.2% to close at $37.72. While the company reported better-than-expected Q2 results, operating income dropped from 2021 levels.
  • Innovid Corp. (NYSE: CTV) fell 13.9% to close at $3.17.
  • Genenta Science S.p.A. (NASDAQ: GNTA) fell 13.5% to close at $4.60.
  • Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares fell 13% to close at $0.5449. Chembio Diagnostics filed for potential stock offering.
  • Cohn Robbins Holdings Corp. (NYSE: CRHC) dipped 12.8% to close at $7.96.
  • MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) fell 12.7% to close at $20.74. The company posted upbeat quarterly earnings, but issued weak FY23 forecast. MasterCraft Boat also sold its NauticStar business to Iconic Marine Group.
  • Mercer International Inc. (NASDAQ: MERC) dipped 12.5% to close at $14.07.
  • The Lovesac Company (NASDAQ: LOVE) dropped 12.4% to close at $26.18 following Q2 results.
  • Erasca, Inc. (NASDAQ: ERAS) fell 11.3% to close at $8.34. Erasca announced preliminary Phase 1/1b monotherapy data for ERK1/2 inhibitor ERAS-007 and SHP2 inhibitor ERAS-601 in BRAF-driven and RAS/MAPK-altered solid tumors.
  • Sylvamo Corporation (NYSE: SLVM) declined 9.8% to close at $36.50.
  • Sabre Corporation (NASDAQ: SABR) dropped 9.5% to close at $6.54 after Mizuho maintained a Neutral rating on the stock and lowered its price target from $8 to $7.
  • Mullen Automotive, Inc. (NASDAQ: MULN) fell 9.3% to close at $0.61 after the company announced it has acquired a 60% controlling interest in Bollinger Motors for $148.2 million in cash and stock.
  • American Eagle Outfitters , Inc. (NYSE: NYSE:AEO) shares fell 8.7% to settle at $10.58 after the company reported worse-than-expected Q2 EPS results.
  • McCormick (NYSE:MKC) & Company, Incorporated (NYSE: MKC) fell 6.7% to close at $79.30. McCormick said it expects third-quarter FY22 sales to increase about 3% year-on-year and 6% in constant currency.
  • Wayfair Inc. (NYSE: W) fell 3.7% to close at $48.81 after the company reported a proposed offering of $600 million convertible senior notes.
  • Grid Dynamics Holdings, Inc. (NASDAQ: GDYN) fell 3.6% to close at $19.08 after the company priced its common stock offering of about 5.71 million shares at $17.50 per share.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
 

Related Articles

How To Invest Like Warren Buffett: 3 Simple Rules
How To Invest Like Warren Buffett: 3 Simple Rules By Benzinga - Nov 26, 2022

Benzinga - Warren Buffett is considered one of the greatest investors of all time because of the strong returns the “Oracle (NYSE:ORCL) of Omaha” has generated for his...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email